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IKCaf carriers, exchangers and “pumps”, the inner mitochondrial membrane contains
ion-conducting channels which endow it with controlled permeability to small ions. Some have been shown
to be the mitochondrial counterpart of channels present also in other cellular membranes. The manuscript
summarizes the current state of knowledge on the major inner mitochondrial membrane channels,
properties, identity and proposed functions. Considerable attention is currently being devoted to two K+-
selective channels, mtKATP and mtBKCa. Their activation in “preconditioning” is considered by many to
underlie the protection of myocytes and other cells against subsequent ischemic damage. We have recently
shown that in apoptotic lymphocytes inner membrane mtKV1.3 interacts with the pro-apoptotic protein Bax
after the latter has inserted into the outer mitochondrial membrane. Whether the just-discovered mtIKCa has
similar cellular role(s) remains to be seen. The Ca2+ “uniporter” has been characterized electrophysiolo-
gically, but still awaits a molecular identity. Chloride-selective channels are represented by the 107 pS
channel, the ﬁrst mitochondrial channel to be observed by patch-clamp, and by a ∼400 pS pore we have
recently been able to fully characterize in the inner membrane of mitochondria isolated from a colon tumour
cell line. This we propose to represent a component of the Permeability Transition Pore. The available data
exclude the previous tentative identiﬁcation with porin, and indicate that it coincides instead with the still
molecularly unidentiﬁed “maxi” chloride channel.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Nature, or evolution, is thrifty. It's logical for it to utilize the same
tools for as many tasks and in as many locations as possible. Especiallycator; BHT, 3,5-di-t-Butyl-4-
nel; CaM, Calmodulin; CLIC,
sporin A; diCl-DHAA, 12,14-
smembrane potential; DIDS,
lectron Microscopy; ER, Endo-
, Human Colon Tumour; 5-HD,
-dependent K+ channel; IMAC,
drial Membrane; IP, Ischemic
-sensitive K+ channel; MAM,
Embryonic Fibroblast; MgTx,
B, 5-nitro-2-(3-phenylpropyla-
brane; PBL, peripheral blood
Membrane; RLM, Rat Liver
eactive Nitrogen Species; ROS,
enase; SITS, 4-acetamido-4′-
-Mitochondrial Particle; SUR,
AC, Voltage-Dependent Anion
science, c/o Department of
Padova, Italy. Tel.: +39 049
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transport appliances such as ion channels, transporters and pumps,
meeting the needs of highly organized cells, full of membrane-bound
compartments. Thus, the increasing evidence [1–3] that some proteins
may be present in more than one cellular structure – often with very
different abundance – should not be cause for surprise. The
mechanisms involved are partly understood (for a discussion see
[3]). The instances already known indicate that all subcellular
compartments may share some proteins with others. Mitochondria
have provided several examples [3–9]. In particular, themitochondrial
channels for which molecular candidates exist appear to represent
subpopulations of channels present also elsewhere. Themechanism of
dual targeting for these channels is not known. None of them harbours
typical N-terminal mitochondrial targeting sequences. However,
targeting information may comprise several distant amino acids
spread throughout the entire protein, as in the case of mitochondrial
carriers [10]. Alternatively, speciﬁc post-translational protein mod-
iﬁcations and differential splicing have been hypothesized to account
for organellar protein targeting [1].
Dual targeting represents a problem, in the sense that it is difﬁcult
to dispel the doubt that the presence in mitochondria might just be an
artefact due to contaminations, insufﬁcient selectivity of antibodies,
etc. These doubts are reasonable, especially when dealing with
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recognized that the association of mitochondria with the ER is so close
that Mitochondria Associated Membranes (MAM; e.g.: [11–14])
constitute a functional sub-domain providing physical contact
between these subcellular compartments. Since MAM are very
difﬁcult to eliminate completely, adequate experimental precautions
must be taken to ascertainwhether the protein(s) under investigation
are located in mitochondria (narrowly deﬁned) or in MAM. This is
particularly relevant when the proteins in question are abundant in
the ER, e.g. in the case of the Ryanodine Receptor, whose presence in
mitochondria has been reported [15,16]. Genetic techniques may be
useful in this respect [3,17–19]. Using a biochemical approach, the
observation that the abundance of a protein in various membranous
fractions increases along with that of mitochondrial markers, while
markers of contaminating membranes decrease, may be considered
good evidence for a mitochondrial location. In the speciﬁc case of
inner mitochondrial membrane channels, an advantage comes from
the ability to conduct patch-clamp experiments involving a limited
portion of membrane, which may be visually observed to be the
“inﬂated” inner membrane of a single swollen mitochondrion. Any
MAM present would be expected to be associated with the outer
membrane, which is largely lost upon swelling and whose remnants
can be observed (and avoided) in a large fraction of the objects in the
ﬁeld of view. In support of an inner membrane location of channels
routinely observed in patch-clamp experiments on mitoplasts one
may invoke a kind of proof ab absurdo: if these channels actually
resided in OMM/MAM residues, this would imply that a large
percentage of seals are actually established on these unstructured
remnants rather than on the much vaster, more accessible and
carefully targeted surface of the inner membrane. It is doubtful that
any high-resistance seal (as distinct from pipette clogging) could
actually be established on OMM/MAM residues, and in fact we feel all
seals formed on swollen mitoplasts ought to be considered as
established on the inner membrane unless proof is provided of the
contrary. These considerations do not apply to electrophysiological
experiments performed with puriﬁed/reconstituted membranes or
single proteins or protein complexes. Furthermore, for these
approaches the objection can always be raised that the properties of
the pores may have been altered during the puriﬁcation, or that their
properties may differ from those in situ due the loss of accessory/
modulating factors.
In this paper we focus on the latest contributions to mitochondrial
channel research from our labs. Only a summary account of recent
work on selected other IMM channels is provided. Excellent recent
reviews are available [20,21]. Two well-characterized IMM channels
are the 107 pS anion-selective channel [22] and the Ca2+ channel
described by Kirichok et al. [23]. We have recently characterized the
“Half-PTP” (HP), an anion channel with a conductance close to one-
half that of the PTP [24]. These three channels will be covered ﬁrst,
beginning with the anion-selective ones. Three more IMM channels,
K+-selective pores to which a putative molecular identity label has
been attached, will be discussed later.
2. Channels of the inner mitochondrial membrane
2.1. IMAC
The anion-selective 107 pS channel, the ﬁrst mitochondrial
channel to be characterized by patch-clamp [22], has been proposed
[25,26] to correspond to the Inner Membrane Anion Channel
(IMAC) previously studied with the tools of bioenergetics [27,28].
The identiﬁcation was based on the comparison between the
pharmacological proﬁles of IMAC as studied by monitoring the
swelling of suspended mitochondria and of the channel observed by
patch-clamp. Channel activity is promoted by stressful circum-
stances: alkalinisation of the matrix, Mg2+ depletion, depolarization(i.e., matrix-side positive potentials in electrophysiological experi-
ments) and ROS or increasingly oxidizing conditions [22,25,28,29].
The functional role(s) of this channel remain in part to be clariﬁed,
but it has been proposed to contribute importantly to the oscillatory
behaviour of the ΔΨm and ROS production by the mitochondrial
network in cardiomyocytes subjected to oxidative stress and to ROS-
induced further ROS production [20,21,30–33]. IMAC activation by
ROS is thought to provide the pathway for superoxide efﬂux from
mitochondria. Interestingly, IMAC/107pS is inhibited or activated by
at least some ligands (PK11195, 4′-chlorodiazepam, FGIN-1-27) of
the Translocator Protein (TSPO) [25,30,34]. The TSPO, formerly
known as the mitochondrial or peripheral benzodiazepine receptor,
is a highly conserved OMM protein believed to be fundamental for
cholesterol transport and membrane biogenesis [35]. These phar-
macological effects have led to the idea that it interacts with and
modulates IMAC [30,32].
2.2. The half-PTP (HP)
Our group has studied the Permeability Transition Pore by
electrophysiological means (reviews on the PT: [36–43]), showing
that its characteristics are compatible with a dimeric structure formed
by two cooperating channels [44–46]. The behaviour of the channel
studied in rodent mitoplasts indicates that states with both channels
open or closed are relatively stable, while a situation with only one of
the twin pores open is not: the lonely channel gates rapidly and a
transition to a longer-lasting stable arrangement follows in short
order. A note of caution: a dimeric organization ﬁts well with models
envisioning formation of the PTP by a carrier of the IMM – be it the
ANT, PiC [42,47] or another one – but since the molecular identity of
the PTP is as uncertain as ever (it has even beenproposed to be formed
by inorganic polymers [48]), there is no deﬁnitive proof of it. The
electrophysiological data are also compatible with a monomeric
channel capable of entering a conformation with a conductance
approximately one-half of maximum.
Stand-alone “hemichannels” (dubbed “HP”, for “Half-PTP”) had
been observed in a few experiments with RLM [44], but too
infrequently for a proper characterization. This however becomes
possible if mitochondria isolated from the human colon tumour
HCT116 cell line are used, since in that system the full-size PTP is
observed much less frequently [24]. In patch-clamp experiments on
mitoplasts of this origin we have thus been able to characterize
electrophysiologically and pharmacologically a channel with a con-
ductance close to one-half that of the PTP. Its relationship to the latter
is conﬁrmed not only by the similarity of their biophysical properties,
but also by the inverse relationship in the frequency of their
appearance in experiments conducted under different conditions or
with mitochondria of different origin. A relatively high likelihood of
observing the PTP is associated with a low probability of observing the
HP, and vice-versa. This implies a very close relationship between the
two pores, which, if unrelated, would be expected to be insensitive to
the other's presence. It furthermore reinforces the notion that the HP
may represent one-half of the PTP dimer. This may be a dissociated
monomer or the active member of a pair comprising a permanently
inactivated channel. Since HP channels often appear in two's or
three's, the HP may also represent a regular PTP couple in which
interaction (and hence cooperation) between the constituents has
been lost.
The HP channel resides in the inner mitochondrial membrane or at
residual contact sites: we recorded HP activity in ﬂuorescent objects
(mitoplasts), isolated from a cell line stably transfected with a
mitochondria-targeted ﬂuorescent DsRed protein, shown by micro-
scopy to localize only in mitochondria; seals were established on
mitochondria swollen beyond the point of outer membrane rupture
(mitoplasts); the HP channel co-localizedwith the 107 pS channel and
the PTP, acknowledged markers of this membrane.
Fig. 1. Reproducibility of HP voltage dependence. (A) A current record obtained by
applying the computer-driven voltage protocol shown in panel C to a patch of HCT116
mitoplast membrane. The mitoplast was obtained by allowing mitochondria to swell in
the presence of 0.5 mM CaCl2 and 1mM Pi. The patch contained two active HP channels.
Ionic conditions: 0.61 (bath) vs. 0.15 (pipette) M KCl. “Leaks” were not subtracted. (B)
The average of 17 consecutive recordings analogous to and including the one shown in
panel A, from the same patch. The pattern of panel A is clearly recognizable, indicating
that the behaviour of the channels is reproducible. (C) The voltage protocol applied:
pipette voltage was ramped between±30 mV as shown. The time scale is the same as
for panels A and B. (D) I–V plot of the data in panel B.
Fig. 2. The HP can transiently adopt cation-selective states. (A) Current record (above)
and applied voltage protocol (below) from a representative experiment on an HCT116
mitoplast. Ionic conditions as indicated. An opening to a cation-selective state can be
observed, followed by a return to anionic selectivity (positive current at 0 applied
voltage at the end of the trace). (B) I–V plot of the data in panel A. While extrapolation
of some segments of the record yields a negative x-axis intercept (i.e. a negative reversal
potential, corresponding to anionic selectivity), extrapolation of others yields a positive
one (cationic selectivity). The leak current was not subtracted.
353M. Zoratti et al. / Biochimica et Biophysica Acta 1787 (2009) 351–363Based on the properties of these pores, we had suggested that
VDAC, the mitochondrial porin, may constitute the ion-conducting
portion of the assembly [45,46]. Single-channel recordings on HCT116
mitoplasts conﬁrmed the strong similarities between the HP and
VDAC, but uncovered some differences. The HP displays Ca2+-
dependence, in the sense that “high” (≥100 μM) Ca2+ is generally
needed to observe sustained activity. Its conductance, about 400 pS in
150 mM KCl, matches that of VDAC (both channels actually exhibit a
range of conductances), but the HP channel is more markedly anion-
selective, with a ratio of permeability coefﬁcients PCl/PK≈7–18.
Puriﬁed VDAC, despite its name, has a lower anion selectivity, with
PCl/PK estimates ranging only up to about 4. The HP channels
displayed voltage sensitivity but with characteristics that differed
from case to case. One can identify three patterns. The HP was
normally open if no transmembrane voltage was applied, but often
showed a VDAC-like tendency to close as the potential was increased
in either a positive or negative direction. In most cases closure took
place at relatively low (≤40 mV) voltages. In other instances closure
occurred more readily at negative than at positive pipette potentials,
but in rare cases the opposite was true. The sensitivity to voltage also
varied, with some channels responding promptly and at low (b40mV)voltages, and others requiring prolonged application of higher
potentials to close. As exempliﬁed by the records in Fig. 1, repeated
applications of standard voltage protocols on the same channel
consistently elicited the same response, so that variability cannot be
ascribed to stochastic variations. We speculated that post-transla-
tional modiﬁcations, possibly phosphorylation, of the protein(s)
affecting the voltage sensor(s) may account for this variability in
voltage-dependence. While, to our knowledge, an asymmetric voltage
dependence of porin has not been reported, this discrepancy might be
ascribed tomodiﬁcations intervening upon isolation of the protein. An
identiﬁcation of HP with VDAC has however been ruled out by the
observation of the former's activity in MEF cells lacking either VDAC-1,
VDAC-2, or both VDAC-1 and -3 [24]. On the other hand, the properties
of HP channel are, as expected, similar to those of the PTP. Both are
anion-selective, but the PTP can occasionally switch to cationic
selectivity for short periods [49,50]. This switch is associated with
unstable states. Similarly, in rare cases the HP channel can give rise to
cation-selective conductances, as exempliﬁed in Fig. 2.
In an attempt to gain clues as to the molecular nature of the pore,
we determined a pharmacological proﬁle which however did not
provide deﬁnitive information [24]. DIDS and SITS (100–300 μM)
inhibited its activity, but other classical inhibitors of anion-selective
channels (NPPB, IAA-94, niﬂumic acid and ﬂufenamic acid) did not.
ATP or Mg2+ at acid pH were also able to inhibit the channel, as was
the reducing agent BHT (Fig. 3). These effects reinforce the link to the
PTP, known to be activated by oxidative conditions. On the other hand,
Cyclosporin A (CSA) did not block the channel, but for some reason
this paramount PT inhibitor is not effective in HCT116 mitochondria
[49,51] (for a discussion of the variable effectiveness of CSA see [38]).
Fig. 3. Inhibition of the HP channel by BHT. In this representative experiment on an
HCT116 mitoplast, 20-mV, 1-second voltage pulses of alternating polarity were applied
sequentially, with a 0.1 s interval at zero voltage between pulses. (A) A column plot of
the mean current ﬂowing in the circuit during each pulse vs. time. Addition of 0.2 mM
3,5-di-t-Butyl-p-HydroxyToluene (BHT) causes closure of the channels, i.e., a decrease
of the mean current. (B–D) Current records corresponding as indicated to the plot
segments identiﬁed by bars and letters in panel A. After the important current decrease
shown in panel B the patch still exhibited some residual low-conductance activity (C),
which eventually disappeared leaving only the leak current (D).
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molecular identity is known are different from those of the HP.
The pores formed in vitro by the puriﬁed adenine nucleotide
translocator, considered until recently to be a core component of
the PTP, had conductances in the 300–600 pS range ([KCl]
=100 mM), with substates, were activated by Ca2+, and their
conductance was decreased by lowering pH in the 7–5 range. But
they closed only at VN100 mV, and were slightly cation-selective
[52,53]. Puriﬁed/reconstituted yeast phosphate carrier [54], brown
adipose tissue uncoupling protein [55] and multiple-location
intracellular CLIC-4 [56] on the other hand have been reported to
form moderately or poorly (CLIC-4) anion-selective pores, but their
conductance is clearly lower than that of the HP. Other CLIC channels
are much “smaller” [57]. Other possible candidates might be the
components of the protein import machinery, whose channel
activity upon reconstitution has been described. Isolated Tim22
was reported to be activated at high voltages [58,59], but a recent
paper [60] reports that in its native membrane it can be observed at
low voltages if challenged with a leader peptide, while it is driven
into closed or inactivated state(s) as the voltage is made more
negative or positive. Tim23 has been identiﬁed [60–63] as the
protein responsible for the mitochondrial Multiple Conductance
Channel activity, which apparently also exhibited sensitivity to TSPO
ligands [34] (see below). Tim22 and Tim23 pores resemble each
other and, at least superﬁcially, the PTP. They show evidence for a
dimeric structure and their conductance and voltage-dependence
may match that of the PTP, but they are cation-selective. Still anothercandidate is provided by the discovery that connexin-43 hemi-
channels are present in cardiac mitochondria [64,65]. Connexons are
known to be regulated by multiple phosphorylations [66–68], but at
least those formed by Cx43 are inactivated by Ca2+ and display little
selectivity and a considerably lower conductance than the HP
channel [69,70]. Other hemi-connexons have suitably larger con-
ductance (e.g.: [71]), but the lack of effect of carbenoxolone, a widely
used gap-junction blocker, on HP activity [24] makes an identiﬁca-
tion of the channel with this type of molecules unlikely.
The properties of the HP channel turned out however to match
exactly those of PM “maxi-chloride channels”, as described, in
particular, by Sabirov et al. [72]. The name indicates an excision- and
swelling-activated, voltage-inactivated (set of) pore(s) recorded in the
plasmamembrane of various cell types (e.g.: [72–74]), which has been
proposed to be implicated in the release of ATP and/or glutamate from
stressed glial cells [75,76]. This correspondence does not allowdecisive
progress in the identiﬁcation of the molecule(s) involved, since the
molecular identity of the “maxi” chloride channel is unknown.
2.3. miCa
The properties of the channel described in [23] are broadly
consistent with its identiﬁcation with the long-sought mitochondrial
Ca2+ uniporter (miCa). For example, it is inhibited by Ru360 and
Ruthenium Red, the permeability ranking of divalent cations is the
same, and its open probability decreases as the transmembrane
potential is lowered. Whole mitochondria have long been known to
have a relatively low afﬁnity for Ca2+ [77]. Indeed, the observation of a
marked increase in intramitochondrial Ca2+ in response to cytosolic
transients not exceeding 1–3 μM as a peak cytoplasmic average value
was surprising and led to the discovery of the “special relationship”
between the ER and mitochondria [12,78–82]. In the patch-clamp
study inhibition of Na+ currents by Ca2+ led to a 2 nM estimate for the
afﬁnity of the uniporter [23]. This difference may be ascribed to the
presence, in intact mitochondria, of regulatory elements (e.g., Mg2+
ions) which may be absent in an electrophysiological setting, and of
Ca2+-exporting mechanisms (e.g. Na+ or H+/Ca2+ antiporters).
Another aspect to be considered is the outward (from the matrix)
uniport-mediated Ca2+ ﬂow. Suspended mitochondria loaded with
Ca2+ readily release it via the uniporter if they are depolarized. miCa
apparently shows inward rectiﬁcation not only when Ca2+ on the
matrix side is low, but also under symmetrical conditions (see
Supplementary Fig. 2 in [23]). Whole-mitochondrion I–V curves
recorded with “symmetrical” [Ca2+] would clarify whether this
rectifying behaviour is compatible with the suspension Ca2+ ﬂux
data. The abundance of the mitochondrial Ca2+ uniporter has been
estimated at ≤1 pmol/mg prot. on the basis of La3+ binding assays
[83]. Kirichok et al. estimated its density at 10–40 channels/μm2 of
IMM surface [23]. Whether the two data are compatible depends on
the area of the IMM associated with 1 mg of mitochondrial protein.
Not many estimates are available for this parameter. Petronilli and
Zoratti [84] obtained a value of 0.92±0.17 μm2/mg prot. for mouse
liver mitochondria, which would translate Kirichok's estimate into
roughly 0.2–0.7 pmol/mg prot., a surprisingly close agreement with
the binding assay data. It should in any case be considered that the
mitochondria used for patch-clampworkwere isolated from COS cells,
while most of the data on Ca2+ transport by populations of isolated
mitochondria and related topics have been obtained using RLM.
The molecular nature of miCa is still mysterious. Its properties
identify it as a Ca2+ channel (rather than, say, a nonselective cation
channel). Characteristically, in the complete absence of Ca2+ it can
conduct Na+ ions, but very low concentrations of Ca2+ essentially
block the Na+ current. This is thought to be due to the high afﬁnity for
Ca2+ of the selectivity ﬁlter, which in PM Ca2+ channels consists of
four Glu residues. The bound Ca2+ can be chased off this binding site
by electrostatic repulsion by another incoming divalent cation, but not
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mitochondria of a protein, or an assembly of proteins, having some
homology to known Ca2+ channels and tale-telling glutamates (or
perhaps aspartates) at the appropriate position. The several mito-
chondrial proteomic studies published so far have however essentially
failed to recognize any mitochondrial channel except the three VDAC
isoforms (e.g.: [85–94]). This reﬂects perhaps a tendency to ascribe to
contaminating material any protein not already known to belong
speciﬁcally to mitochondria (the “eclipse effect”), as well as technical
difﬁculties ascribable to their hydrophobic nature and especially to
their low abundance [95,96]. In general, aside from porin, aquaporin
and mechanosensitive channels in bacteria, which are relatively
abundant, only very few channel proteins have been identiﬁed by
proteomics.
2.4. Mito KATP
An activity identiﬁed as corresponding to that of the ATP-
sensitive K+ channel was described early in the history of
mitochondrial electrophysiology [97], but to this day it remains a
matter of controversy, with perhaps most of the opinionated
favouring its presence in mitochondria, but some articulate oppo-
nents (e.g.: [98–102]).
PM KATP channels are composites of a K+-conducting portion
belonging to the inwardly-rectifying Kir family (Kir6.1 or Kir6.2), and a
regulator protein belonging to the ABC transporter class (SUR1 or
SUR2; the latter comes in two variants) which largely determines the
pharmacological properties of the channel [103]. Unbelievers point
out that these putative components have not so far been unequi-
vocally identiﬁed as components of the mitochondrial proteome (but
see the comment above). Biochemical approaches have produced both
afﬁrmative and negative results, and have so far failed to convince
skeptics despite a number of reports conﬁrming the presence of KATP
subunits in mitochondria. A detailed review of the literature cannot be
given here, but some information is included to provide an idea of the
unenviable state of the ﬁeld. Accounts can be found in recent papers
and in reviews [20,21,77,101–107].
Thus, e.g., Bajgar et al. reported that an isolate obtained from brain
mitochondria via an ATP afﬁnity column contained two proteins of 55
and 63 kDa apparent MW (assigned to a Kir and SUR subunit,
respectively) [108]. Upon incorporation into liposomes this fraction
was able to reconstitute K+ transport with pharmacological char-
acteristics matching those of mtKATP. Mironova et al. observed the
channel in planar bilayer experiments using protein fractions isolated
from mitochondria prepared by standard methods [109–111]. In
studies of this type it is not always clear whether the precautions
adopted were sufﬁcient to prevent contamination artefacts. Suzuki et
al. found Kir6.1 in the inner membrane of muscle and liver
mitochondria by immunoﬂuorescence and immunogold EM [112].
Lacza et al. used immunogold EM, Western blotting and other
methods to conclude that Kir6.1 and Kir6.2 are present in isolated
puriﬁed mouse heart and brain mitochondria [113,114]. Mitochon-
dria-addressing sequences were putatively identiﬁed in the proteins'
sequences. Abe's group also identiﬁed Kir6.1 in rat brain [115] and
kidney [116] mitochondria by immunomicroscopy. Western blot
evidence for Kir6.1 in the mitochondria of an amoeba has been
obtained [117]. But recent work by the Marbàn group suggests that
anti-Kir antibodies may recognize unrelated mitochondrial proteins
[118]. Peptides with the MW expected for SUR1 or SUR2 were not
detected by Lacza et al. [113]. The commercial anti-SUR2 antibody
used recognized instead a 25-kDa protein, and the authors concluded
that functional mtKATP channels are present in heart mitochondria. A
glibenclamide-binding protein of similar size, considered to be a SUR-
like component of mtKATP, had also been observed in beef heart SMPs
[119]. Both SUR2A and SUR2B were instead detected as higher MW
peptides (∼50 and ∼120 kDa) in rat heart cardiomyocyte mitochon-dria by Western blotting and immunoelectron microscopy using
antibodies made in-house [120].
Evidence in favor of a functional mtKATP channel comes from
electrophysiological observations, obtained via both patch-clamp
experiments on mitochondria [97,121] and planar bilayer recordings
of activity after fusion of IMM vesicles or incorporation of isolated
protein fractions [107,109–111,122–128]. The characteristics of the
channels identiﬁed, on the basis of pharmacological effects, as mtKATP
in electrophysiological experiments differ somewhat. Inoue et al.,
patching RLM mitoplasts, described a channel with a single channel
conductance (g) of 9–10 pS in 100 mM (pipette)/33 mM (bath) KCl.
The I–V relationship was nearly linear, with only a slight outward
rectiﬁcation [97]. The channel of Dhalem et al. (the only other patch-
clamp study) exhibited a similar conductance at negative potentials,
but rectiﬁed more steeply, with g exceeding 80 pS at VN60 mV [121].
In early planar bilayer experiments with puriﬁed proteins Paucek et al.
measured about 30 pS in 1 M KCl [122]. These authors considered this
value to be in fair agreement with Inoue's, since the channel was
expected to exhibit saturation with increasing [KCl]. Mironova et al.
reconstituted protein fractions which produced channels of about
10 pS in symmetrical 100 mM KCl [109–111]. The major conductance
observed by Zhang et al. after fusing inner mitochondrial membrane
vesicles with the planar bilayer, in symmetrical 150mMKCl, measured
∼56 pS [123], while Bednarczyk et al. observed an essentially ohmic
conductance of ∼103 pS under the same conditions [107,127,128]. The
differences in conductance can however be ascribed at least in large
part to a recognized cooperative behaviour of these channels, which
appear to often occur in clusters [97,109,111]. Redox sensitivity
[123,124,126,129,130] may further contribute to complexity.
In many cases the presence, properties and roles of mtKATP have
been inferred indirectly from experiments employing isolated
mitochondria or reconstituted proteoliposomes and pharmacological
tools (e.g.: [131–133]). Many of these studies rely on monitoring K+
ﬂuxes as indirectly measured by swelling of the mitochondria,
changes in mitochondrial potential, oxygen consumption or variations
in pH or K+ content as revealed by indicator dyes. This class of
experiments, in particular the ones involving measurements of
mitochondrial volume, have been criticized in particular by Halestrap
and coworkers, who, e.g., did not obtain ﬁrm evidence for an increase
of mitochondrial volume following application of mtKATP activator
diazoxide [98,101].
All considered, it seems fair to conclude that ROS-, GTP-, GDP-,
UDP-, diazoxide-activated, ATP-, ADP-, Mg2+-, NO-, quinine-, 5-HD-,
glybenclamide-inhibited K+-selective channels are likely to be
present or can be formed in the IMM of various tissues and cells.
The molecular composition of the mtKATP channel remains
however an open question. Information about this key point was
sought by comparing the properties and pharmacology of an activity
assigned to mtKATP with those of surface channels of deﬁned
molecular composition formed by Kir and SUR subunits produced in
HEK293 cells from transfected cDNAs [134,135]. In both studies
activity of heterologously expressed, surface-located Kir-SUR combi-
nations (or of native cardiac myocyte channels) was assessed by
whole-cell patch-clamping, while activity of the mtKATP counterparts
was assessed indirectly by monitoring the ﬂuorescence of mitochon-
drial ﬂavine nucleotides. This latter method reports on the redox state
of these groups, which is a function of the Δµ˜H maintained across the
IMM. Thus, it reports the degree of depolarization or of uncoupling of
the mitochondria themselves. Opening of mtKATP channels would
indeed be expected to lead to mitochondrial depolarization. The
method was adopted on the basis of the observation [136] that
diazoxide – which opens mitochondrial but not plasma membrane
KATP channels in cardiac myocytes [137,138] – induced a decrease in
the ﬂuorescence of ﬂavin nucleotides. Its validity has later been
challenged [139]. These comparisons along with imaging studies led
to the conclusion thatmtKATP in the heart is “distinct from surface KATP
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SUR2A, the subunits of the PM KATP in these cells [134]. A match was
found instead between the pharmacological proﬁles of ﬂuorescence
variations linked to mtKATP activity in myocytes and of current
conduction by the Kir6.1/SUR1 combination [135]. In view of other
data, however, the identiﬁcation was considered tentative by the
authors themselves.
In 2004 Ardehali et al. [140], building on previous results showing
that diazoxide and 5-HD affected succinic dehydrogenase activity as
well as mtKATP [141], reported the puriﬁcation of a complex of 5
mitochondrial proteins, including succinate dehydrogenase. Upon
reconstitution in planar lipid bilayers this preparation produced
channels with g ∼200 pS in 500 vs. ∼30 mM KCl. K+ selectivity was
not pronounced, but this was tentatively ascribed to the presence of –
SH reducing agents. Importantly, the activity (and the permeability of
proteoliposomes to K+) responded to modulators in the manner
expected if it were due to mtKATP. Furthermore SDH inhibitors, but not
ANT inhibitors, affected both permeability to K+ of liposomes and
channel activity in planar membranes. Malonate, a well-known SDH
inhibitor, was recently conﬁrmed to activate mtKATP (monitored as
mitochondrial swelling) [142].
mtKATP presumably participates in the regulation of mitochondrial
ionic homeostasis, but the real reason so much interest is concen-
trated on this particular mitochondrial channel is the role it may play
in ischemic preconditioning (IP). IP consists of brief sub-lethal
ischemic periods that are capable of protecting against subsequent
massive ischemia [143]. The discovery of “chemical preconditioning”
by KATP openers [144] and its subsequent attribution to mitochondrial
KATP [132,137,145] spawned a whole ﬁeld of research. The reader is
referred to several excellent recent reviews for a complete overview
[101,102,105,106,146–157]. The phenomenon has been studiedmost in
the context of cardioprotection, but it has also been observed for
skeletal muscle (e.g.: [158,159]) and other organs. It goes without
saying that this is also a ground of dispute, with skeptics pointing out
the multiplicity of other effects of mtKATP agonists and antagonists.
The mechanism of preconditioning has not been established yet, but
clearly it is a complicated process involving various cellular signalling
pathways, with a major role played by PKCɛ, as well as possibly other
mitochondrial channels (mtBKCa, PTP, hemi-connexon 43) besides
mtKATP. It might actually be more appropriate to consider a role for
mitochondrial K+ inﬂux rather than for mtKATP activation, since
opening of mtBKCa also seems to result in protection (see below). A
key facet of the mechanism seems to be ROS (and RNS [154,160])
production at mitochondria [101,154,161,162]. In one scheme the end
effect of preconditioning is to reduce oxidative stress during
ischemia/reperfusion, i.e., to decrease the extent of Permeability
Transition in the infarcted organ (Ca2+-elicited PTP opening has long
been known to be strongly potentiated by thiol oxidation; see e.g.
[163]). This end effect is thought to be the only apparently paradoxical
consequence of a (more limited) ROS production during precondi-
tioning (e.g. [101] and refs therein). According to one view, these
would have the effect – via still poorly deﬁned ways – of activating
PKCɛ (e.g. [164–166]) and other kinases, whose signalling would
converge in the end in the phosphorylation and inhibition of GSK3β.
The latter has been reported to act at mitochondria to facilitate
opening of the PTP and cell death [167–170]. A point that has not been
adequately clariﬁed is how mtKATP opening should lead to increased
ROS production. In fact some results suggest that the channel may be
not upstream but rather downstream of ROS generation caused by
other phenomena (in particular, when diazoxide is used as a
preconditioning agent, by inhibition of SDH) [101,139,171,172].
Another view is that mtKATP opening is by itself responsible for the
protectingmechanism (e.g.: [173]). This relates to the observation that
mild uncoupling by various means before ischemia is protective
(reviewed in [101]). Opening of mtKATP would be expected to cause a
decrease of Δψm. The mechanism of signal transduction leading toprotection is however at least as obscure in this scheme as in the one
envisioning ROS.
In conclusion, there is as yet no general consensus on the role of
mtKATP in preconditioning protection.
2.5. Ca2+-activated K+ channels
Given the relevance of Ca2+ in mitochondrial physiology, and
given the impact Ca2+ handling by mitochondria has on cellular
processes, it is not surprising that the IMM has been found to
contain Ca2+-activated channels. One special case of such a
channel is the PTP, brieﬂy mentioned above. Mitochondrial
editions of two Ca2+-dependent K+ channels present and studied
in the PM have been described. One is mtBKCa (KCa1.1 [174]),
observed by direct patch-clamping of mitoplasts [175–178] as well
as in planar lipid bilayer experiments [179]. Evidence has also been
provided by Western blot, electron microscopy and immunoﬂuor-
escence microscopy [176,179,180]. The identity has been conﬁrmed
by pharmacological studies employing selective toxins, and the
presence of this channel in mitochondria appears to be less
controversial than that of KATP, even though doubts have been
voiced, mainly on grounds of possible contamination by other
membranes [101]. The channel is activated by Ca2+ in the μM
range and also in other respects seems to conform to the PM
channel model (for which see, e.g.: [181–184]). The latter channel,
called “Big” because of its 100–300 pS conductance, is known to
be a tetramer of α subunits (occurring in splice variants) crossing
the membrane 7 (rather than 6 as in KV channels) times, with the
N terminus outside and a large C-terminus domain in the
cytoplasm. This domain contains the Ca2+-binding “bowl” and
protein–protein interaction motifs (“leucine zippers”) and phos-
phorylation sites known to be used by PKA and other kinases.
BKCa's are also voltage-dependent due to the presence of a
positively charged S4 segment, the movement of which induces
opening upon depolarization. Based on the observed voltage-
dependence (opening favored by matrix-positive, unphysiological,
potentials), the orientation of mtBKCa in the IMM can thus be
deduced to be the same as in the PM. Four (plus splice variants)
membrane-inserted, N-terminal-interacting auxiliary β subunits are
known, and account for a certain organ-dependent variability in
the channels' properties [185]. The β1 subunit has been proposed
to be associated with mtBKCa in cardiac mitochondria [177], while
a recent publication reports that the mitochondrial channel in
neurons speciﬁcally comprises the β4 subunit (KCNMB4) [180].
BKCa channels of the PM are very useful negative feedback tools as
they can counteract depolarization and Ca2+ entry via voltage-
dependent Ca2+ channels by opening and promoting (re)polarization
(e.g. [186]). mtBKCa is believed to carry out a similar feedback
regulatory role linking matrix [Ca2+] to IMM K+ permeability and
mitochondrial volume [176]. Recent studies have found evidence for a
role in acute hypoxia sensing (hypoxia increases Po) and of a
functional interaction with the PTP [178,187].
As in the case of mtKATP, much interest concentrates on this pore
because of the protective role its opening has been reported to afford
against I/R damage to the heart and other organs [176,177,188–195]. In
this case any effects may well be attributed to a mitochondrial
channel, since BKCa seems not to be expressed in the PM of
cardiomyocytes. Since both mtKATP and mtBKCa activation lead to an
increase in the K+ permeability of the IMM and thus to an increased K
+ inﬂux, the ﬁndings that activation of each protects from damage
reinforce the case for a role by both or either (e.g. [196]). The
mechanism of protection would be predicted to be the same.
Coherently, mtBKCa activation is reported to lead to an increased
rate of respiration and to increased production of ROS by mitochon-
dria, which would be a key factor in delayed protection (but a ROS
decrease has also been reported; e.g.: [193]). Again, the matter is
Fig. 4. Treatment of CTLL-2/KV1.3 cells with 20 μM C6-ceramide from a stock solution in
DMSO results in cytochrome c release while cells lacking KV1.3 fail to respond to
apoptotic stimuli. Cytosolic fractions of whole cell lysates obtained following the
indicated treatments were loaded on SDS-PAGE and Western blotted with anti-
cytochrome c antibodies. To measure the release of mitochondrial cytochrome c, cells
were washed after stimulation in cold HEPES/Saline, incubated for 30 min at 4 °C in
220 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH (pH 7.3), 50 mM KCl, 2 mM
MgCl2, 1 mM DTT, 5 mM succinate-KOH (pH 7.3), 10 μM cytochalasin B, and 10 μg/ml A/
L, and ﬁnally Dounce-homogenized. Samples were centrifuged, proteins (20 μg) in the
supernatants were separated on 15% SDS-PAGE and blotted onto a nitrocellulose
membrane. Western blots were analyzed using a monoclonal mouse anti-cytochrome c
antibody (clone 7H8.2C12, BD Pharmingen, San Diego, CA) and the Tropix ECL system.
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is based on the ﬁnding that NS1619, a BKCa activator, induces
preconditioning-like protection in the heart. Like for diazoxide and
5-HD in the case of mtKATP, there is however concern that this may
well be due to other, mtBKCa-independent effects such as induction of
ROS generation (by an unidentiﬁed mechanism) [197–200]. Analo-
gous concerns have not been voiced with regard to the converse
protection-abolishing effect of BKCa blockers, most often paxilline.
Again, why ROS production should be increased upon increasing IMM
permeability to K+ remains unclear. Recently two novel BKCa agonists,
NS11021 [201,202] and diCl-DHAA [192,203] have been used, produ-
cing much the same protective effects. A new blocker, HMIMP, has
also become available [204].
The other two families of Ca2+-activated K+ channels, as deﬁned
on the basis of channel conductance, are the small (2–25 pS)
conductance SKCa [205,206] and the intermediate (25–100 pS)
conductance IKCa (KCa3.1 [174]) [207–211]. There is no information
on the presence of the former in mitochondria, but the latter has
recently been discovered in the inner membrane of human colon
tumour (HCT116) mitochondria (De Marchi et al., submitted).
Plasmamembrane IKCa (revs.: [212,213]) is presentmainly in blood
and in epi- and endothelial cells. In the latter, it aids ﬂuid secretion by
providing a pathway for K+ efﬂux. Along with KV1.3, it is the major K+
channel in subpopulations of activated T cells (for details see
[213,214]). Like the other Ca2+-activated K+ channels, it provides a
feedback mechanism whereby cytoplasmic Ca2+ increase results in a
hyperpolarizing response counteracting depolarization associated
with Ca2+ inﬂux and sustaining Ca2+ entry. This circuit is important
for progression through the cell cycle. Given the widespread presence
of the channel in cancer cells, it is therefore under consideration as a
target for anti-tumoural as well as immunosuppressive intervention
(e.g.: [215]). Ca2+ sensitivity is due to the tight, Ca2+-independent
association of calmodulin at the C terminus (e.g.: [216]). The KD for
Ca2+ binding to the calmodulin EF hands is ∼300 nM, thus any signi-
ﬁcant increase above the resting level of approximately 1–200 nM
Ca2+ causes channel opening. There is, instead, no dependence of the
open probability on voltage: like KV channels, IKCa is formed by 4
subunits each spanning the membrane six times, but the S4 segment
lacks the necessary charged residues. The channel is selectively
inhibited by maurotoxin and by some triarylmethane derivatives, of
which the most powerful (tens of nM range) and useful are
clotrimazole and TRAM-34 [215,217].
In mitochondria the protein is present at low levels, but it can be
clearly detected in Western blots. In keeping with its low abundance,
only a few copies of the channel are observed by patch-clamp in any
given membrane patch. The biophysical and pharmacological
properties of the mitochondrial IKCa are indistinguishable from
those of the IKCa activity recorded in the PM of the same cells, which
in turn is analogous to that previously described in a number of
other cells.
PM IKCa is very sensitive to [Ca2+], set to open as soon as its levels
rise above resting. The presence of the same channel in the IMM and
its orientation imply the presence of calmodulin in the mitochondrial
matrix, in agreement with reports of calmodulin in these organelles
[218,219]. Mitochondria have also been reported to contain CaM-
binding proteins [220–225]. Thus, the presence and functions of this
paradigmatic Ca2+-sensitivity conferring protein inmitochondriamay
well be a rewarding ﬁeld of investigation.
Just how widespread mtIKCa is needs to be established. If it were
present in most untransformed cell types, it could be considered to be
a constitutive component of the mitochondrial system of K+
“uniporters” [21,43,77,131,226]. At the cellular level, mtIKCa may be
expected to have protective roles similar to those proposed for mtKATP
andmtBKCa (see above). On the other hand, it might instead – or also –
have a role in cell death, in analogy to the function recently discovered
for KV1.3 in lymphocyte mitochondria (see below).2.6. mtKV1.3
We have recently identiﬁed another potassium-selective channel,
KV1.3 [227], in the inner mitochondrial membrane of lymphocytes
[228]. This is a member of the much-studied voltage-dependent
Shaker-like family [212,229–231]. Brieﬂy, this large family of gene
products forms tetrameric ion-conducting assemblies, generally
associated with a tetramer of one of a number of β subunits. The
key feature, besides K+ selectivity, is voltage dependence, consisting
in rapid depolarization-induced opening, followed by inactivation.
KV1.3 is the predominant type of voltage-gated KV channel
expressed in the plasma membrane in human lymphocytes (e.g.:
[232]). Activation of KV1.3 channels in T cells is a key event in
proliferation, so that speciﬁc inhibitors of KV1.3 have a strong
immunosupressant effect [214]. Suppression of KV1.3 activity upon
stimulation of the CD95 cell death receptor or treatment with C6-
ceramide has been linked to the early, induction phase of apoptosis in
T lymphocytes [233,234]. While early inactivation of plasma mem-
brane KV1.3 seems to be important in the initiation of apoptosis by
some stimuli, e.g., C6-ceramide or CD95 [233–235], other stimuli, e.g.,
the cytostatic drug Actinomycin D, seem to activate the channel in a
later phase of apoptosis, signalling execution [236]. An apoptosis-
induced increase of plasma membrane KV1.3 activity has been
observed to be downstream of caspase-8 activation [237]. These
studies leave little doubt that the KV1.3 is deeply involved in the
regulation of apoptosis, but genetic proof was required for a full
demonstration.
As a genetic model, we used CTLL-2 lymphocytes, known to be
deﬁcient for KV1.3 [238] (CTLL-2/pJK), and stably transfected these
cells with Kv1.3 (CTLL-2/Kv1.3). The biophysical characteristics of
KV1.3 in the plasma membrane of CTLL-2/KV1.3 cells were identical to
those of endogenous KV1.3 in Jurkat T lymphocytes, indicating the
suitability of this genetic model to analyze the function of KV1.3. To
analyze the functional importance of KV1.3 for the induction of
apoptosis, we incubated KV1.3-deﬁcient CTLL-2 cells, KV1.3-reconsti-
tuted CTLL-2/KV1.3, Jurkat lymphocytes or activated human periph-
eral blood lymphocytes (PBL) with tumour necrosis factor α (TNFα),
staurosporine, sphingomyelinase, C6-ceramide or Actinomycin D
[236,238]. Analogous experiments were performed using siRNA
targeting KV1.3. KV1.3-expressing cells responded within 12 h with
DNA fragmentation, cytochrome c release, mitochondrial depolariza-
tion and morphological alterations typical of apoptosis, whereas
KV1.3-deﬁcient CTLL-2/pJK cells were resistant. Fig. 4 illustrates
signiﬁcant differences in C6-ceramide-induced cytochrome c release
between CTLL-2/pJK and CTLL-2/KV1.3 cells. Dihydro-C2-ceramide, an
inactive relative of C2- and C6-ceramides, did not induce release of
Fig. 6. Increased production of ROS by MgTx- or Bax-treated Jurkat mitochondria. ROS
production by mitochondria was monitored as the generation of H2O2 in the presence
of Superoxide Dismutase using the Amplex Red ﬂuorimetric assay (Molecular Probes)
according to the manufacturer's instructions. Mitochondria (corresponding to 1×106
cells) were suspended in a stirred, thermostated (25 °C) 2 ml cuvette in a Perkin
Elmer LS50B ﬂuorimeter in 50 mM KCl, 170 mM sucrose, 20 mM HEPES/K+ (pH 7.4),
2 mM MgCl2, 5 mM EGTA, 5 mM succinate, 1 U/ml Superoxide Dismutase (0.1 mg/
prot/ml), 15 μg/ml Horseradish Peroxidase and 10 μM Amplex Red. Fluorescence was
sampled at 100 min−1. The data were normalized so as to give the same slope of the
linear ﬁt of the ﬁrst segment (before any addition) and to eliminate variations due to
the use of different amounts of mitochondria (because of different preparation purity
levels) and/or different ROS detection efﬁciency in the experiments. The relative rate
of H2O2 production after additions was evaluated from the slope of the ﬁt of the linear
portion of the relevant trace segments, as illustrated. Inset: averages of the
normalized slopes (mean±SD; n=3) of change in ﬂuorescence upon GST-Bax
treatment in similar experiments with mitochondria isolated from the indicated cell
types (differences are signiﬁcant, pb0.05, for Kv1.3-positive mitochondria, but not for
CTLL-2/pJK mitochondria).
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that prolonged (24–36 h) incubation of CTLL-2/pJK cells with these
stimuli eventually resulted in death, suggested that KV1.3 functions
upstream of cytochrome c release and may be involved in an
ampliﬁcation loop such as the mitochondrial pathway mediating
apoptosis. These data prompted us to investigate the subcellular
localization of KV1.3.
Evidence was found for a previously undescribed mitochondrial
localization of the KV1.3 in genetically non-manipulated lymphocytes
[228]. The molecular identity of the channel was assessed by
comparing mitochondria isolated from the CTLL-2 line with those
from CTLL-2 cells stably transfected with KV1.3. The channel was
shown to be present in mitochondria by Western blot, immunogold
labelling and FACS analysis. Recent work suggests that also other KV
channels, in particular KV1.5, might be expressed in mitochondria
[240]. Most importantly, patch-clamp on mitoplasts indicated the
presence of an activity compatible with that of the plasma membrane
KV1.3 in mitochondria isolated from Jurkat and CTLL-2/KV1.3 but not
in those from CTLL-2/pJK. Fig. 5 shows co-localization of the inner
membrane hallmark 107 pS channel and of KV1.3 in mitochondria
isolated from Jurkat cells. Both channels were identiﬁed on the basis of
their biophysical and pharmacological properties. In particular, the
slope conductance of mtKV1.3 was approximately 25 pS, a weak
rectiﬁcation was observed at negative potentials in symmetrical high
K+ solution, as expected for KV1.3 [241] and the channel was inhibited
from the periplasmic (non-matrix) side by Margatoxin (MgTx), a
speciﬁc inhibitor of KV1.3. The observed activity displayed potassium
selectivity and was only slightly voltage-dependent [228]. This last
feature differs from the behaviour of plasma membrane KV1.3,
indicating that the channel is differently modulated in mitochondria.
In fact, the channel seems to be active even at the very negative
resting mitochondrial potential, i.e. at approximately−180mV, and is
likely to be at least partially responsible for the much studied “basal”
K+ conductance in these organelles [77]. Activity of the channel could
not be observed directly by patch-clamp at those high voltages, but
speciﬁc inhibition of mtKV1.3 by MgTx induces hyperpolarization as
assessed by indicator dyes. The electrochemical gradient for K+
predicts that K+ should enter the matrix through an IMM-located
potassium channel. If inﬂux becomes inhibited, a hyperpolarization is
expected. Hyperpolarization in turn results in the reduction of
respiratory chain components such as Fe/S centers, cytochromes
and the ubiquinone pool, and in enhanced production of reactive
oxygen species (ROS) (e.g.: [20,162]). In agreement, MgTx addition to
isolated mitochondria in suspension resulted in ROS production as
illustrated in Fig. 6 (lower trace). ROS are able to oxidize thiol groups
and thus to elicit mitochondrial depolarization by activation of the PTP
[36,242,243]. PTP opening and consequentΔψm decrease downstream
of transient mitochondrial hyperpolarization and/or increase in ROSFig. 5. Co-presence of mtKV1.3 and the 107 pS channel in the same patch of a Jurkat
mitoplast. Level 1: current conductedbyopenmtKV1.3. Level 2: 107pS channel.Medium:
symmetrical 134mMKCl,1mMCaCl2,1mMMgCl2,10mMHEPES/KOH (pH 7.4),10mM
EGTA/KOH. Voltage: 60 mV. Sampling frequency: 10 kHz. Filter: 200 Hz.production has been reported in several studies employing drugs or
Ca2+-overload to induce apoptosis (e.g.: [244–246]). In our case,
MgTx-induced hyperpolarization was indeed followed by CSA-
sensitive depolarization, indicating that PTP opening was eventually
induced by MgTx [239]. Although PTP opening often requires Ca2+
accumulation in thematrix, some inducers, including SH reagents, can
function at very low external Ca2+. ROS have also been shown to
oxidize cardiolipin resulting in the release of cytochrome c from the
inner mitochondrial membrane [247,248]. Independently of whether
the PTP is related or not to cytochrome c release, KV1.3 has been
shown to be crucial for cytochrome c release whenmitochondriawere
challenged with MgTx (Fig. 7). Thus according to our model inhibition
of KV1.3 by speciﬁc drugs (MgTx and Shk, another inhibitor of KV1.3)
induces ROS production which ﬁnally results in cytochrome c release
from KV1.3-positive mitochondria.
The work summarized above left open the question whether the
release of cytochrome c by KV1.3 inhibitors has any physiological
signiﬁcance. In other words: is there any physiological stimulus that
could inhibit mitochondrial KV1.3 and thereby induce cytochrome c
release during apoptosis? MgTx and Shk are positively charged
peptides that interact with negatively charged residues in the KV1.3
protein vestibule to block the pore. All toxins that block KV1.3 contain
a lysine which is critical for the interaction with KV1.3 [249,250]. A
model of the structure of the membrane-integrated Bax monomer
indicates that at least amino acids 127 and 128, located between the
Fig. 7. Margatoxin induces cytochrome c release from KV1.3-expressing mitochondria.
Isolated and puriﬁed CTLL-2/Kv1.3 or CTLL-2/pJK mitochondria were incubated with
20 nM MgTx for 30 min and the release of cytochrome c was determined. The Western
blots show the cytochrome c content in mitochondria prior and after treatment with
MgTx as well as the corresponding amount of cytochrome c in the supernatant of the
same mitochondrial preparations. To determine cytochrome c release from isolated
mitochondria, cells were incubated for 30 min at 4 °C in 0.3 M sucrose, 10 mM TES (pH
7.4), and 0.5 mM EGTA and Dounce-homogenized. Nuclei and unbroken cells were
pelleted by centrifugation for 5 min at 600 ×g and 4 °C. Supernatants were centrifuged
at 6000 ×g for 10 min at 4 °C, and mitochondria were further puriﬁed using 10-min
Percoll gradient centrifugation at 4 °C (60%, 30%, 18% Percoll in the buffer as above,
8500 ×g). Mitochondria at the interface between the 30% and 60% layers were
collected, washed twice, and resuspended in 50 mM PIPES-KOH (pH 7.4), 50 mM KCl,
2 mM MgCl2, 2 mM EGTA, 10 μg/ml A/L, 2 mM ATP, 10 mM phosphocreatine, 5 mM
succinate, and 50 μg/ml creatine kinase (buffer 1). Mitochondria were then incubated
for 30 min on ice with 20 nM MgTx, respectively, and centrifuged; supernatants were
discarded and the mitochondria were resuspended in 37 °C prewarmed buffer 1.
Samples were incubated for 5 min at 37 °C and the reaction was terminated by
addition of one volume ice-cold buffer 1, centrifugation at 14,000 rpm for 10 min at
4 °C and addition of SDS-sample buffer. The samples were analyzed for cytochrome c
release by Western blotting.
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into the intermembrane space [251]. Interestingly, the amino acid in
position 128 is a highly conserved, positively charged lysine, which
may mimic the action of the critical lysine in KV1.3-blocking toxins by
binding to the ring of 4 aspartate residues of the channel vestibule. As
mentioned above, the channel vestibule faces the intermembrane
space. As we expected, Bax turned out to inhibit KV1.3. Immunopre-
cipitation and patch-clamp data showed that Bax interacts with the
vestibule region of KV1.3 [239]. Like MgTx, Bax induced an increase of
ROS production by isolated mitochondria (Fig. 6, upper trace and
inset). Our results identify mtKV1.3 as a novel target for Bax and
indicate that mtKV1.3 is required for induction of apoptosis by Bax in
lymphocytes. The role of mtKV1.3 was underscored in experiments in
which incubation of isolated mitochondria with recombinant Bax
triggered apoptotic alterations only in mitochondria expressing
mtKV1.3. The amino acid residue K128 in Bax seems indeed to be
particularly important for the interaction of Bax with mtKV1.3, since
mutation of this lysine to glutamic acid abrogated inhibition of KV1.3
by Bax and the pro-apoptotic activity of Bax [239]. Our data altogether
suggest that Bax and the toxins ShK and MgTx act on KV1.3 in a
functionally similar way.
3. Conclusion and perspectives
Our knowledge of mitochondrial IMM channels is advancing, albeit
slowly. Much remains to be done. The molecular identities of the
107pS channel, of the HP and the PTP, and of the miCa remain open
questions. The controversy about the existence of mtKATP, mtBKCa and
their role in preconditioning is likely to continue for some time.
Obtaining answers will probably require a systematic investigation
combining inventive genetic, biochemical and electrophysiological
approaches. The presence of mtKV1.3 and mtIKCa channels in the
mitochondria of cell types other than the ones in which they were
discovered needs to be considered. It is possible that other channels
of the KV and KCa families (and others?) might comprise a mito-
chondrial population. Preconditioning and related controversies
aside, the role of these various channels in mitochondrial and cellularphysiology deﬁnitely deserves further investigation, with an eye to
possible pharmacological exploitation.
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